These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders? Romagnani S Allergy; 2006 Jan; 61(1):3-14. PubMed ID: 16364151 [TBL] [Abstract][Full Text] [Related]
25. Oral Tolerance Development and Maintenance. Wambre E; Jeong D Immunol Allergy Clin North Am; 2018 Feb; 38(1):27-37. PubMed ID: 29132672 [TBL] [Abstract][Full Text] [Related]
26. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368 [TBL] [Abstract][Full Text] [Related]
27. A review of allergy and allergen specific immunotherapy. Bidad K; Nicknam MH; Farid R Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):1-9. PubMed ID: 21358009 [TBL] [Abstract][Full Text] [Related]
29. Adjuvants and vector systems for allergy vaccines. Moingeon P; Lombardi V; Saint-Lu N; Tourdot S; Bodo V; Mascarell L Immunol Allergy Clin North Am; 2011 May; 31(2):407-19, xii. PubMed ID: 21530828 [TBL] [Abstract][Full Text] [Related]
30. Sublingual immunotherapy: the quest for innovative adjuvants. Goldman M Clin Exp Allergy; 2008 Nov; 38(11):1705-6. PubMed ID: 18721252 [No Abstract] [Full Text] [Related]
31. Allergen-specific immunotherapy: update on immunological mechanisms. Alvaro M; Sancha J; Larramona H; Lucas JM; Mesa M; Tabar AI; Martinez-Cañavate A; ; Allergol Immunopathol (Madr); 2013; 41(4):265-72. PubMed ID: 23332741 [TBL] [Abstract][Full Text] [Related]
32. Immunotherapy: the next 100 years. Finegold I; Oppenheimer J Ann Allergy Asthma Immunol; 2010 Nov; 105(5):394-8. PubMed ID: 21055667 [No Abstract] [Full Text] [Related]
33. Novel therapeutic strategies by regulatory T cells in allergy. Elkord E Chem Immunol Allergy; 2008; 94():150-157. PubMed ID: 18802345 [TBL] [Abstract][Full Text] [Related]
34. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy. Bohle B Arch Immunol Ther Exp (Warsz); 2002; 50(4):233-41. PubMed ID: 12371619 [TBL] [Abstract][Full Text] [Related]
35. Modifying allergens and using adjuvants for specific immunotherapy. Larché M; Ferreira F; Mohapatra SS Clin Allergy Immunol; 2004; 18():641-61. PubMed ID: 15042940 [No Abstract] [Full Text] [Related]
36. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890 [TBL] [Abstract][Full Text] [Related]
37. Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy. Möbs C; Slotosch C; Löffler H; Pfutzner W; Hertl M Int Arch Allergy Immunol; 2008; 147(3):171-8. PubMed ID: 18594146 [TBL] [Abstract][Full Text] [Related]
38. Targeting dendritic cells in allergen immunotherapy. Novak N Immunol Allergy Clin North Am; 2006 May; 26(2):307-19, viii. PubMed ID: 16701146 [TBL] [Abstract][Full Text] [Related]
39. Current world literature. Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):603-7. PubMed ID: 21030837 [No Abstract] [Full Text] [Related]